Hypophosphorylation of the RB protein in S and G2 as well as G1 during growth arrest

Experimental Cell Research

Volumn 241, Issue 2, 1998, Pages 324-331

  Yen, Andrew ^a   Sturgill, Rhonda ^a  

^a Department of Obstetrics Gynecology   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; CELL CYCLE G1 PHASE; CELL CYCLE S PHASE; CELL GROWTH; CELL PROLIFERATION; DNA SYNTHESIS INHIBITION; GROWTH INHIBITION; HUMAN; HUMAN CELL; LEUKEMIA CELL; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN DOMAIN; PROTEIN PHOSPHORYLATION; TRANSCRIPTION REGULATION; TUMOR SUPPRESSOR GENE;

EID: 0032526759     PISSN: 00144827     EISSN: None     Source Type: Journal    
DOI: 10.1006/excr.1998.4007     Document Type: Article

References (39)

1. Zacksenhaus E., Bremner R., Jiang Z., Gill R. M., Muncaster M., Sopta M., Phillips R. A., Gallie B. L. Unraveling the function of the retinoblastoma gene. Adv. Cancer Res. 61:1993;115-141.
2. Levine A. J. The tumor suppressor genes. Annu. Rev. Biochem. 62:1993;623-651.
3. Weinberg R. A. Tumor suppressor genes. Science. 254:1991;1138-1146.
4. Yen A., Pardee A. B. Exponential 3T3 cells escape in mid-G1 from their high serum requirement. Exp. Cell Res. 116:1978;103-113.
5. Dou Q. P., Levin A. H., Zhao S., Pardee A. B. Cyclin E and cyclin A as candidates for the restriction point protein. Cancer Res. 53:1993;1493-1497.
6. Dowdy S. F., Hinds P. W., Louie K., Reed S. I., Arnold A., Weinberg R. A. Physical interaction of the retinoblastoma protein with human D cyclins. Cell. 73:1993;499-511.
7. Hinds P. W., Mittnacht S., Dulic V., Arnold A., Reed S. I., Weinberg R. A. Regulation of retinoblastoma protein functions by ectopic expression of human cyclins. Cell. 70:1992;993-1006.
8. Shirodkar S., Ewen M., DeCaprio J. A., Morgan J., Livingston D. M., Chittenden T. The transcription factor E2F interacts with the retinoblastoma product and a p107-cyclin A complex in a cell cycle-regulated manner. Cell. 68:1992;157-166.
9. Zukerberg L. R., Benedict W. F., Arnold A., Dyson N., Harlow E., Harris N. L. Expression of the retinoblastoma protein in low-grade B-cell lymphoma: Relationship to cyclin D1. Blood. 88:1996;268-276.
10. Pier Paolo C., De Luca A., Howard C. M., Baldi A., Firpo E. J., Koff A., Paggi M. G., Giordano A. Functional analysis of pRb2/p130 interactions with cyclins. Cancer Res. 56:1996;2003-2008.
11. Burger C., Wick M., Muller R. Lineage-specific regulation of cell cycle gene expression in differentiating myeloid cells. J. Cell Sci. 107:1994;2047-2054.
12. Yen A., Williams M., Platko J. D., Der C., Hisaka M. Expression of activated RAF accelerates cell differentiation and RB protein down regulation but not hypophosphorylation. Eur. J. Cell Biol. 65:1994;103-113.
13. Yen A., Varvayanis S. Late dephosphorylation of the RB protein in G2 during the process of induced cell differentiation. Exp. Cell Res. 214:1994;250-257.
14. Zhang W., Hittleman W., Van N., Andreeff M., Deisseroth A. The phosphorylation of retinoblastoma gene product in human myeloid leukemia cells during the cell cycle. Biochem. Biophys. Res. Commun. 184:1992;212-216.
15. Ikeda M. A., Jakoi L., Nevins J. R. A unique role for the RB protein in controlling E2F accumulation during cell growth and differentiation. Proc. Natl. Acad. Sci. USA. 93:1996;3215-3220.
16. Cavanaugh A. H., Hempel W. M., Taylor L. J., Rogalsky V., Todorov G., Rothblum L. I. Activity of RNA polymerase I transcription factor UBF blocked by Rb gene product. Nature. 374:1995;177-180.
17. Dunaief D. L., Strober B. E., Guaha S., Khavari P. A., Alin K., Luban J., Begemann M., Crabtree G. R., Goff S. P. The retinoblastoma protein and BRG1 form a complex and cooperate to induce cell cycle arrest. Cell. 79:1994;119-130.
18. Strober B. E., Dunaief J. L., Guha S., Goff S. P. Functional interactions between the hBRM-hBRG1 transcriptional activators and the pRB family of proteins. Mol. Cell. Biol. 16:1996;1576-1583.
19. Singh P., Coe J., Hong W. A role for retinoblastoma protein in potentiating transcriptional activation by the glucocorticoid receptor. Nature. 374:1995;562-565.
20. White R. J., Trouche D., Martin K., Jackson S. P., Kouzarides T. Repression of RNA polymerase III transcription by the retinoblastoma protein. Nature. 382:1995;88-90.
21. Adnane J., Shao Z., Robbins P. D. The retinoblastoma susceptibility gene product represses transcription when directly bound to the promoter. J. Biol. Chem. 270:1995;8837-8843.
22. Hagemeier C., Cook A., Kouzarides T. The retinoblastoma protein binds E2F residues required for activation in vivo and TBP binding in vitro. Nucleic Acids Res. 21:1993;4998-5004.
23. Dean D. C., Luo R. X., Chow K. N. B. Mechanism of action of the Rb tumor suppressor. Proc. Am. Assoc. Cancer Res. 38:1997;648-649.
24. Chow K. N. B., Starostick P., Dean D. C. The Rb family contains a conserved cyclin-dependent-kinase-regulated transcriptional repressor motif. Mol. Cell. Biol. 16:1996;7173-7181.
25. Larminie C. G. C., Cairns C. A., Mital R., Martin K., Kouzarides T., Jackson S. P., White R. J. Mechanistic analysis of RNA polymerase III regulation by the retinoblastoma protein. EMBO J. 16:1997;2061-2071.
26. Kim Y. W., Otterson G. A., Kratzke R. A., Coxon A. B., Kaye F. J. Differential specificity for binding of retinoblastoma binding protein 2 to RB, p107, and TATA-binding protein. Mol. Cell. Biol. 14:1994;7256-7264.
27. Hateboer G., Timmers H. T. M., Rustgi A. K., Billaud M., Van't-Veer L. J., Bernards R. TATA-Binding Protein and the retinoblastoma gene product bind to overlapping epitopes on c-myc and adenovirus E1A Protein. Proc. Natl. Acad. Sci. USA. 90:1993;8489-8493.
28. Pilz R. B., Van den Berghe G., Boss G. R. Induction of HL-60 differentiation by starvation for a single essential amino acid but not by protein synthesis inhibitors. J. Clin. Invest. 79:1987;1006-1009.
29. Collins S. J., Gallo R. C., Gallagher R. E. Continuous growth and differentiation of human myeloid leukaemic cells in suspension culture. Nature. 270:1977;347-349.
30. Breitman T. R., Selonick S. E., Collins S. J. Induction of differentiation of the human promyelocytic leukemia cell line (HL-60) by retinoic acid. Proc. Natl. Acad. Sci. USA. 77:1980;2936-2940.
31. Yen A. HL-60 cells as a model of growth control and differentiation: The significance of variant cells. Hematol. Rev. 4:1990;5-46.
32. Dalton W. T., Ahearn M. J., McCredie K. B., Freireich S. J., Stass S. A., Turjillo J. M. HL-60 cell line was derived from a patient with FAB-M2 and not FAB-M3. Blood. 71:1988;242-247.
33. Yen A., Reece S. L., Albright K. L. Dependence of HL-60 myeloid cell differentiation on continuous and split retinoic acid exposures: Pre-commitment memory associated with altered nuclear structure. J. Cell. Physiol. 118:1984;277-286.
34. Yen A., Forbes M., deGala G., Fishbaugh J. Control of HL-60 cell differentiation lineage specificity: A late event occurring after precommitment. Cancer Res. 47:1987;129-134.
35. Yen A., Forbes M. E., Varvayanis S., Tykocinski M. L., Groger R. K., Platko J. D. C-FMS dependent HL-60 cell differentiation and regulation of RB gene expression. J. Cell. Physiol. 157:1993;379-391.
36. Yen A., Soong S., Kwon H. J., Yoshida M., Beppu T., Varvayanis S. Enhanced cell differentiation when RB is hypophosphorylated and down-regulated by radicicol, a SRC-kinase inhibitor. Exp. Cell Res. 214:1994;163-171.
37. Yen A., Chandler S. Inducers of leukemic cell differentiation cause down-regulation of RB gene expression. Proc. Soc. Exp. Biol. Med. 199:1992;291-297.
38. Yen A., Chandler S., Forbes M. E., Fung Y.-K., T'Ang A., Pearson R. Coupled down-regulation of the RB retinoblastoma and c-myc genes antecedes cell differentiation: Possible role of RB as a "Status Quo" gene. Eur. J. Cell Biol. 57:1992;210-221.
39. Brooks C. III, Kazmer S., Levin A. A., Yen A. Myeloid differentiation and retinoblastoma phosphorylation changes in HL-60 cells induced by retinoic acid receptor- and retinoid X receptor-selective retinoic acid analogs. Blood. 87:1996;227-237.